1) high-risk acute coronary syndromes
高危不稳定型心绞痛/非ST段抬高心肌梗死
1.
Objective:To determine the optimal strategy for the use of glycoprotein Ⅱb / Ⅲa (Gp Ⅱb / Ⅲa) inhibitors in patients with high-risk acute coronary syndromes (ACS) receiving an early invasive treatment.
方法:选择接受早期冠脉介入治疗(PCI)的高危不稳定型心绞痛/非ST段抬高心肌梗死(UA/NSTEMI)患者162例,按替罗非班使用时机分常规早期治疗组和延期选择性治疗组,分别评估两种治疗方案对PCI术前、术后心肌组织水平灌注和30天复合心血管事件发生率的影响。
2) unstable angina/non-ST-elevation myocardial infarction
不稳定型心绞痛/非ST段抬高心肌梗死
4) non-ST elevation myocardial infarction
非ST段抬高心肌梗死
1.
In them 83 patients had ST elevation myocardial infarction(STEMI),69 patients had non-ST elevation myocardial infarction(NSTEMI)and 69 patients had unstable angina(UA).
方法:入选末次症状发作至就诊时间均<6h的ACS患者221例,分为ST段抬高心肌梗死(STEMI)组(n=83)、非ST段抬高心肌梗死(NSTEMI)组(n=69)和不稳定性心绞痛(UA)组(n=69)。
2.
Objective To observe the clinical effect and safety intreatment of non-ST elevation myocardial infarction(NSTEMI) with Tirofiban Methods 86patients with acute NSTEMI were divided into treatment and control group randomly.
目的观察替罗非班治疗急性非ST段抬高心肌梗死(NSTEMI)的临床疗效及安全性。
3.
Objective: To observe the clinical effect and safety in treatment of non-ST elevation myocardial infarction(NSTEMI) with clopidogrel.
目的:观察氯吡格雷治疗急性非ST段抬高心肌梗死(NSTEMI)的临床疗效及安全性。
5) Non-ST-segment elevation myocardial infarction
非ST段抬高心肌梗死
1.
Investigation on the effect factors of non-ST-segment elevation myocardial infarction;
非ST段抬高心肌梗死相关因素探讨
6) ST elevation myocardial infarction
ST段抬高型心肌梗死
1.
The prediction value of brain natriuretic peptide in patients with ST elevation myocardial infarction;
脑利钠肽对ST段抬高型心肌梗死患者的预后价值
补充资料:高危
1.位高势危。旧多指君王位高骄妄以致危亡。语出《孝经.诸侯》:"在上不骄,高而不危。" 2.指尊高的帝位。 3.高而险的地方。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条